Training for the Prevention and Treatment of Stroke in China
Training for the Prevention and Treatment of Stroke in China
批准号:
8094299
负责人:
DANIEL T LASKOWITZ
金额:
$14.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-06-30
关键词:
AdultAwardCause of DeathChinaChronic DiseaseClinical ResearchCollaborationsDoctor of PhilosophyFacultyFellowshipInstitutesLeadMaster of ScienceMentorsMethodsModelingPhysiciansPolicy ResearchPopulation ResearchPreventionPrincipal InvestigatorResearchResearch ActivityResearch InstituteResearch PersonnelResearch Project GrantsResearch TrainingScientistStrokeTrainers TrainingTrainingTraining ProgramsUniversitiescareerdisabilityglobal healthprogramspublic health relevanceresponseskillssymposium
中文摘要
描述(由申请人提供):针对千禧年承诺奖(PAR-08-175;非传染性慢性病研究培训计划),杜克大学临床研究所(DCRL PD/主要研究员:Daniel Laskowitz医学博士)、杜克全球卫生研究所(DGHI首席研究员:Michael Merson医学博士)、杜克中风中心(DSC首席研究员:Larry Goldstein,MD)和北京大学乔治研究所中国(北京大学首席研究员:吴阳峰,医学博士)建议在中国建立一个卒中预防和治疗培训计划“卒中研究培训计划”。在杜克大学和北京大学之间已经建立的合作伙伴关系的基础上,SRTP的主要目标是为北京大学职业生涯早期和中期的内科科学家提供以中风为重点的临床、人口和政策研究培训。从杜克大学全球健康和临床研究培训计划的理学硕士课程中吸取教训,对早期职业研究人员的长期培训将使他们获得杜克大学全球卫生硕士学位(第二学位)。中期培训将为职业生涯中期的北大内科科学家提供以方法为重点的研究培训,在培训教员的模型中寻求特定的研究技能。所有受训人员都将接触到DSC活动,包括DSC卒中奖学金,以及DSC、DCR1和DGHI正在进行的临床研究项目。短期培训将在北京大学举行的年度学术研讨会上提供,并通过相关的专题讨论会和辅导活动提供。项目结束后,学员将与杜克大学和北大教师导师合作,积极参与北大的研究活动。中风是中国的主要死因,也是导致成年人残疾的主要原因。拟议中的合作将提高杜克大学/北京大学合作的研究质量和可持续性,并将培养将为中国中风的预防和治疗做出贡献的研究人员。
公共卫生相关性:中风是中国死亡的主要原因,也是成人残疾的主要原因。拟议中的合作将提高杜克大学/北京大学合作的研究质量和可持续性,并将培养将为中国中风的预防和治疗做出贡献的研究人员。
英文摘要
DESCRIPTION (provided by applicant): In response to the Millennium Promise Awards (PAR-08-175; Non-communicable Chronic Diseases Research Training Program) the Duke Clinical Research Institute (DCRl PD/Principal Investigator: Daniel Laskowitz, MD), the Duke Global Health Institute (DGHI Principal Investigator: Michael Merson, MD), the Duke Stroke Center (DSC Principal Investigator: Larry Goldstein, MD) in collaboration with Peking University and the George Institute China (PKU Principal Investigator: Yangfeng Wu, MD, PhD) propose to establish a training program in the prevention and treatment of stroke in China, the "Stroke Research Training Program (SRTP)." Building on an already established partnership between Duke University and Peking University, the main objective of the SRTP is to provide stroke-focused training in clinical, population and policy research for early to mid-career physician scientists from Peking University. Drawing from courses in Duke's Master of Science in Global Health and Clinical Research Training Program, long-term training for early career researchers will lead to a (second degree) MSc in Global Health from Duke University. Medium-term training will provide methods-focused research training for mid-career PKU physician scientists seeking a specific research skill in a train the trainer's model. All trainees will be exposed to DSC activities, including the DSC stroke fellowship, and to ongoing clinical research projects in the DSC, the DCRl and the DGHI. Short-term training will be provided in a yearly academic symposium to be held at PKU and by associated topic-focused colloquia and mentoring activities. Upon completion of the program, trainees will be actively involved in PKU research activities in collaboration with Duke and PKU faculty mentors. Stroke is a leading cause of death in China and is a major cause of adult disability. The proposed collaboration will enhance the research quality and sustainability of the Duke/PKU collaboration and will train researchers who will contribute to the prevention and treatment of stroke in China.
PUBLIC HEALTH RELEVANCE: Stroke is a leading cause of death in China and is a major cause of adult disability. The proposed collaboration will enhance the research quality and sustainability of the Duke/PKU collaboration and will train researchers who will contribute to the prevention and treatment of stroke in China.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training for the Prevention and Treatment of Stroke in China
-
批准号:8690195
-
项目类别:
-
资助金额:$13.79万
-
财政年份:2010
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Training for the Prevention and Treatment of Stroke in China
-
批准号:8508326
-
项目类别:
-
资助金额:$13.51万
-
财政年份:2010
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Training for the Prevention and Treatment of Stroke in China
-
批准号:7944954
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2010
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Training for the Prevention and Treatment of Stroke in China
-
批准号:8294647
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2010
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Evaluation of pH Dependent Neuroprotectants in SAH Model
-
批准号:7483998
-
项目类别:
-
资助金额:$14.41万
-
财政年份:2008
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
ApoE-mimetic peptides protect against brain injury
-
批准号:6740771
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2003
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
ApoE-mimetic peptides protect against brain injury
-
批准号:6557298
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2003
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL NEURON SPECIFIC TOXIN
-
批准号:2763662
-
项目类别:
-
资助金额:$11.17万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL NEURON SPECIFIC TOXIN
-
批准号:6531075
-
项目类别:
-
资助金额:$9.69万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL NEURON SPECIFIC TOXIN
-
批准号:6637676
-
项目类别:
-
资助金额:$9.97万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL ACTIVATION PATHWAYS--REGULATION BY APOE
-
批准号:2762233
-
项目类别:
-
资助金额:$7.31万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL NEURON SPECIFIC TOXIN
-
批准号:6187948
-
项目类别:
-
资助金额:$9.86万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
MICROGLIAL NEURON SPECIFIC TOXIN
-
批准号:6363910
-
项目类别:
-
资助金额:$10.11万
-
财政年份:1999
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
APOLIPOPROTEIN E EFFECT ON THE CNS IMMUNE RESPONSE
-
批准号:2472689
-
项目类别:
-
资助金额:$9.67万
-
财政年份:1998
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
APOLIPOPROTEIN E EFFECT ON THE CNS IMMUNE RESPONSE
-
批准号:6187508
-
项目类别:
-
资助金额:$10.9万
-
财政年份:1998
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Apolipoprotein E effect on the CNS immune response
-
批准号:6334444
-
项目类别:
-
资助金额:$10.8万
-
财政年份:1998
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
APOLIPOPROTEIN E EFFECT ON THE CNS IMMUNE RESPONSE
-
批准号:2891431
-
项目类别:
-
资助金额:$9.67万
-
财政年份:1998
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
Apolipoprotein E effect on the CNS immune response
-
批准号:6529051
-
项目类别:
-
资助金额:$10.8万
-
财政年份:1998
-
负责人:DANIEL T LASKOWITZ
-
依托单位:
海外基金